| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 77.302 | 79.902 | 71.352 | 77.364 | 83.696 | 88.791 | 86.552 | 82.851 | 76.329 | 103.700 |
| Total Income - EUR | 77.302 | 79.902 | 71.352 | 77.364 | 83.696 | 88.791 | 86.552 | 82.851 | 76.329 | 103.700 |
| Total Expenses - EUR | 74.422 | 76.605 | 70.279 | 76.796 | 82.362 | 87.565 | 86.066 | 85.861 | 75.802 | 101.877 |
| Gross Profit/Loss - EUR | 2.880 | 3.297 | 1.073 | 568 | 1.333 | 1.226 | 486 | -3.010 | 527 | 1.823 |
| Net Profit/Loss - EUR | 2.213 | 2.498 | 360 | -206 | 494 | 497 | -276 | -3.838 | 322 | 1.364 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Viovir S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.219 | 3.570 | 3.171 | 2.750 | 4.318 | 4.469 | 3.714 | 2.295 | 2.684 | 4.693 |
| Inventories | 3.081 | 2.042 | 2.273 | 1.507 | 3.957 | 3.260 | 3.023 | 1.830 | 2.257 | 3.966 |
| Receivables | 142 | 787 | 157 | 616 | 253 | 135 | 180 | 161 | 238 | 344 |
| Cash | 996 | 742 | 741 | 627 | 108 | 1.074 | 511 | 304 | 189 | 384 |
| Shareholders Funds | -521 | -244 | 120 | -88 | 407 | 896 | 601 | -3.236 | -2.904 | -1.523 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.739 | 3.814 | 3.051 | 2.839 | 3.911 | 3.573 | 3.114 | 5.531 | 5.588 | 6.217 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Viovir S.r.l.